Dirk Rades

Dirk Rades's AcademicInfluence.com Rankings

Dirk Rades

Medical

#3126

World Rank

#3581

Historical Rank

Oncology

#212

World Rank

#220

Historical Rank

medical Degrees

Dirk Rades

Philosophy

#8990

World Rank

#12479

Historical Rank

Logic

#5996

World Rank

#7466

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Dirk Rades's Degrees

Doctorate Medicine University of California, San Francisco
PhD Radiation Oncology University of California, San Francisco

Why Is Dirk Rades Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dirk Rades's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline (2012) (557)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials (2009) (554)
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. (2005) (317)
Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. (2006) (280)
Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. (2004) (194)
Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. (2011) (167)
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. (2009) (162)
Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. (2001) (151)
Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. (2010) (149)
The role of external beam radiotherapy in the management of bone metastases. (2006) (149)
Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. (2002) (145)
The first score predicting overall survival in patients with metastatic spinal cord compression (2008) (129)
Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. (2001) (118)
Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? (2004) (116)
The role of radiotherapy for metastatic epidural spinal cord compression (2010) (109)
A New Scoring System to Predicting the Survival of Patients Treated with Whole-Brain Radiotherapy for Brain Metastases (2008) (108)
Stereotactic radiosurgery alone versus resection plus whole‐brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients (2007) (106)
Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. (2003) (101)
Whole‐brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases (2007) (98)
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. (2009) (97)
Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. (2010) (93)
Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. (2006) (92)
Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). (2016) (89)
Prognostic value of the MIB-1 labeling index for central neurocytomas (2004) (89)
Treatment options for central neurocytoma (2002) (86)
Treatment of atypical neurocytomas (2004) (85)
A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression (2004) (83)
Therapeutic options for meningeal melanocytoma. Case report. (2001) (82)
Health-Related Quality of Life in Long Term Breast Cancer Survivors Treated with Breast Conserving Therapy: Impact of Age at Therapy (2005) (82)
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis. (2009) (81)
Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression (2010) (81)
Treatment recommendations for the various subgroups of neurocytomas (2006) (80)
Spinal reirradiation after short-course RT for metastatic spinal cord compression. (2005) (79)
Central neurocytoma: A multi-disciplinary review (2009) (77)
Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. (2008) (76)
Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. (2011) (75)
Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. (2010) (75)
Well-differentiated neurocytoma: what is the best available treatment? (2005) (73)
A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. (2008) (72)
Dose escalation of radiotherapy for Metastatic Spinal Cord Compression (MSCC) in patients with relatively favorable survival prognosis (2011) (72)
Dose-escalation study for cardiac radiosurgery in a porcine model. (2014) (71)
Prognostic factors for functional outcome and survival after reirradiation for in‐field recurrences of metastatic spinal cord compression (2008) (69)
Therapy of meningeal melanocytomas (2004) (69)
Treatment of painful bone metastases (2010) (65)
Dose‐escalation of whole‐brain radiotherapy for brain metastasis in patients with a favorable survival prognosis (2012) (64)
Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. (2006) (61)
Brain endothelial TAK1 and NEMO safeguard the neurovascular unit (2015) (61)
Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases (2008) (60)
Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. (2006) (60)
A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care (2013) (56)
Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma? (2003) (56)
Reduction of overall treatment time in patients irradiated for more than three brain metastases. (2007) (56)
Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. (2011) (55)
Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. (2007) (55)
The role of postoperative radiotherapy for the treatment of gangliogliomas (2010) (55)
Radiochemotherapy Including Cisplatin Alone versus Cisplatin + 5-Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck (2009) (54)
Comparison of Short-Course versus Long-Course Whole-Brain Radiotherapy in the Treatment of Brain Metastases (2008) (51)
Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules. (2002) (50)
Palliative radiotherapy--new approaches. (2011) (49)
The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita. (2017) (49)
Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. (2008) (49)
The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. (2008) (49)
International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. (2012) (48)
Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas (2006) (48)
Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation. (2015) (48)
Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review. (2019) (47)
Metastatic spinal cord compression (1999) (47)
Evaluation of 2 whole‐brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients (2007) (47)
Dose–response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature (2006) (46)
Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer (2001) (46)
Comparison of electron IMRT to helical photon IMRT and conventional photon irradiation for treatment of breast and chest wall tumours. (2010) (45)
A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. (2013) (44)
Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. (2007) (44)
Prevalence of targetable oncogenic mutations and genomic alterations in Epstein–Barr virus-associated diffuse large B-cell lymphoma of the elderly (2015) (44)
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN) (2011) (42)
Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases (2007) (42)
A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer (2012) (41)
Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression. (2011) (41)
Toxicity of two cisplatin‐based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer (2008) (41)
A boost in addition to whole‐brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients (2007) (41)
Defining the optimal dose of radiation after incomplete resection of central neurocytomas. (2003) (41)
Late Effects and Cosmetic Results of Conventional Versus Hypofractionated Irradiation in Breast-Conserving Therapy (2005) (41)
The prognostic impact of tumor cell expression of estrogen receptor‐α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer (2012) (40)
Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. (2006) (40)
Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. (2007) (39)
Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer. (2008) (39)
Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. (2010) (39)
Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression. (2005) (38)
Radiotherapy beyond cancer: target localization in real-time MRI and treatment planning for cardiac radiosurgery. (2014) (38)
Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck. (2011) (38)
Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: Stereotactic radiosurgery versus surgical resection (2013) (37)
Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway (2015) (37)
The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors (2017) (36)
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis (2010) (36)
Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial. (2000) (36)
Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology (2013) (35)
Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer (2017) (35)
Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients (2007) (34)
Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis. (2011) (34)
Metastatic Spinal Cord Compression Influence of Time between Onset of Motoric Deficits and Start of Irradiation on Therapeutic Effect (1999) (33)
A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. (2009) (33)
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. (2013) (32)
Hyperglycemia in Stroke Impairs Polarization of Monocytes/Macrophages to a Protective Noninflammatory Cell Type (2016) (32)
Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis (2012) (32)
Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. (2008) (31)
Radiotherapy of metastatic spinal cord compression in very elderly patients. (2007) (31)
Metastatic spinal cord compression in non-small cell lung cancer patients (2012) (30)
Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases (2016) (30)
Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases (2013) (30)
A validated survival score for breast cancer patients with metastatic spinal cord compression (2012) (30)
Radiotherapy for Oligometastatic Disease in Patients with Spinal Cord Compression (MSCC) from Relatively Radioresistant Tumors (2010) (30)
A survival score for patients with metastatic spinal cord compression from prostate cancer (2012) (30)
Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer (2008) (30)
Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer. (2006) (30)
Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression. (2005) (29)
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study. (2006) (28)
Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy (2005) (28)
Treatment planning for spinal radiosurgery (2018) (28)
Dose Escalation in Patients Receiving Whole-Brain Radiotherapy for Brain Metastases from Colorectal Cancer (2010) (28)
Breathing-motion-compensated robotic guided stereotactic body radiation therapy (2018) (27)
Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma (2019) (27)
Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration (2005) (27)
A new survival score for patients with brain metastases from non-small cell lung cancer (2013) (26)
Defining the best available treatment for neurocytomas in children (2004) (26)
Whole-Brain Radiotherapy with 20 Gy in 5 Fractions for Brain Metastases in Patients with Cancer of Unknown Primary (CUP) (2007) (26)
Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. (2011) (26)
Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. (2006) (26)
Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action (2015) (26)
Single brain metastasis: whole‐brain irradiation plus either radiosurgery or neurosurgical resection (2012) (26)
Metastatic spinal cord compression in patients with cancer of unknown primary (2012) (26)
A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone (2014) (26)
Androgen receptor expression (2013) (26)
Comparison of Different Treatment Approaches for One to Two Brain Metastases in Elderly Patients (2008) (25)
Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases. (2017) (25)
Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose? (2010) (25)
A Comparison of Two Different Radiation Schedules for Metastatic Spinal Cord Compression Considering a New Prognostic Factor (2002) (25)
Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary (2012) (25)
Radiolabeled Cetuximab plus Whole-Brain Irradiation (WBI) for the Treatment of Brain Metastases from Non-Small Cell Lung Cancer (NSCLC) (2010) (25)
Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation. (2012) (24)
Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? (2012) (24)
Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity (2011) (24)
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma (2017) (24)
Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors (2018) (24)
Single brain metastasis: Radiosurgery alone compared with radiosurgery plus up‐front whole‐brain radiotherapy (2012) (23)
Treatment Planning Considerations for Robotic Guided Cardiac Radiosurgery for Atrial Fibrillation (2016) (23)
The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. (2008) (23)
Shorter-course whole-brain radiotherapy for brain metastases in elderly patients. (2011) (23)
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers (2016) (23)
Extracranial metastatic patterns on occurrence of brain metastases (2011) (23)
A new score predicting the survival of patients with spinal cord compression from myeloma (2012) (22)
Single brain metastasis: Resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery (2012) (22)
Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy. (2009) (22)
Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses. (2015) (22)
Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? (2012) (22)
Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression (2012) (21)
[The value of radiotherapy in treatment of meningeal melanocytoma]. (2002) (21)
A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. (2014) (21)
Effectiveness of Hypofractionated Radiotherapy in Painful Bone Metastases Two Prospective Studies with 1 × 4 Gy and 4 × 4 Gy (1999) (21)
Is 50 Gy Sufficient to Achieve Long-Term Local Control after Incomplete Resection of Typical Neurocytomas? (2006) (21)
Prevalence and Characteristics of Pneumonitis Following Irradiation of Breast Cancer (2019) (21)
[Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome]. (2002) (21)
Brain metastasis from non-small cell lung cancer (NSCLC) (2013) (21)
Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita (2015) (21)
The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. (2007) (21)
Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention (2018) (21)
The first survival score for patients with brain metastases from small cell lung cancer (SCLC) (2013) (20)
Time of Developing Motor Deficits before Radiotherapy as a New and Relevant Prognostic Factor in Metastatic Spinal Cord Compression: Final Results of a Retrospective Analysis (2001) (20)
The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. (2012) (20)
[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]. (2003) (19)
Impact of VEGF and VEGF Receptor 1 (FLT1) Expression on the Prognosis of Stage III Esophageal Cancer Patients after Radiochemotherapy* (2008) (19)
A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone (2013) (19)
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT (2018) (19)
Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer (2012) (19)
Genomic landscape of pancreatic neuroendocrine tumors. (2014) (18)
Is Short-Course Radiotherapy with High Doses per Fraction the Appropriate Regimen for Metastatic Spinal Cord Compression in Colorectal Cancer Patients? (2006) (18)
Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review). (2015) (18)
Radio(chemo)therapy Plus Resection Versus Radio(chemo)therapy Alone for the Treatment of Stage III Esophageal Cancer* (2007) (18)
Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases. (2018) (18)
Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. (2006) (18)
Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer. (2012) (18)
Impact of zoledronic acid on control of metastatic spinal cord compression (2012) (17)
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance (2018) (17)
Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck (2011) (17)
A simple survival score for patients with brain metastases from breast cancer (2013) (17)
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis (2018) (17)
Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis. (2015) (17)
Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma (2016) (16)
Craniospinal Axis Irradiation in Children Treatment in Supine Position Including Field Verification as a Prerequisite for Anesthesia without Intubation (1999) (16)
Spondylodiscitis in patients with spinal cord compression: a possible pitfall in radiation oncology. (2001) (16)
Treatment of Solitary Brain Metastasis (2004) (16)
Side effects of radiotherapy in breast cancer patients (2018) (16)
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations. (2019) (16)
Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer. (2016) (16)
A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy (2018) (16)
Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma. (2015) (16)
Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck (2013) (16)
Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes. (2014) (15)
Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model (2007) (15)
A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). (2019) (15)
Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck (2013) (15)
Expression of Wnt-1, TGF-β and related cell-cell adhesion components following radiotherapy in salivary glands of patients with manifested radiogenic xerostomia. (2011) (15)
A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases (2017) (15)
Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b (2016) (15)
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases (2013) (15)
Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC) (2016) (15)
Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC) (2010) (14)
Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder. (2010) (14)
Epoetin‐α during radiotherapy for stage III esophageal carcinoma (2005) (14)
Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. (2011) (14)
Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression (2014) (14)
Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder. (2018) (14)
Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer (2021) (14)
Precision radiotherapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial. (2019) (14)
EVI1 as a Marker for Lymph Node Metastasis in HNSCC (2020) (14)
Preliminary Results from a Prospective Study Comparing White Blood Cell and Neutrophil Counts from a Laboratory to Those Measured with a New Device in Patients with Breast Cancer (2018) (14)
A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer. (2016) (14)
Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer. (2015) (13)
Predicting Survival After Irradiation for Brain Metastases from Head and Neck Cancer. (2015) (13)
Experiences with a New High-Dose-Rate Brachytherapy (HDR-BT) Boost Technique for T3b Prostate Cancer (2007) (13)
Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer (2018) (13)
Radioprotective Effect of Lidocaine on Neurotransmitter Agonist-Induced Secretion in Irradiated Salivary Glands (2013) (13)
Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018 (2019) (13)
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma (2021) (13)
Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer. (2017) (13)
Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder. (2016) (13)
Radiation Therapy for Metastatic Spinal Cord Compression in Patients with Hepatocellular Carcinoma. (2015) (13)
Brain metastasis (2013) (13)
A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer (2015) (13)
Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors. (2017) (13)
A Scoring System to Predict the Development of Bone Metastasis After Radical Resection of Colorectal Cancer. (2017) (13)
Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery. (2014) (13)
An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer (2018) (13)
Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC). (2016) (12)
Predicting overall survival in patients with brain metastases from esophageal cancer. (2014) (12)
A liquid fluorescence dosimeter for proton dosimetry (2012) (12)
A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases (2017) (12)
Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer (2018) (12)
Improvement of dose calculation in radiation therapy due to metal artifact correction using the augmented likelihood image reconstruction (2018) (12)
External validation of a model to predict the survival of patients presenting with a spinal epidural metastasis (2011) (12)
Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery? (2014) (12)
A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases. (2015) (12)
Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas. (2005) (11)
Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks? (2016) (11)
Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer. (2017) (11)
Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. (2007) (11)
[Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)]. (2005) (11)
Karnofsky Performance Score, Radiation Dose and Nodal Status Predict Survival of Elderly Patients Irradiated for Limited-disease Small-cell Lung Cancer. (2016) (11)
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study (2019) (11)
Prognostic factors for local control and survival in patients with spinal cord compression from myeloma (2012) (11)
Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone? (2007) (11)
Stereotactic radiosurgery for newly diagnosed brain metastases (2014) (11)
Prevalence and Characteristics of Symptomatic Pneumonitis After Radiotherapy of Patients With Locally Advanced Lung Cancer (2019) (11)
Clinical course and survival in patients with squamous cell carcinoma of the maxillary alveolus and hard palate: Results from a single-center prospective cohort. (2019) (11)
Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer. (2017) (11)
A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression (2013) (11)
A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer (2018) (11)
Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group (2008) (11)
Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. (2015) (10)
Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer? (2016) (10)
Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition (2021) (10)
Metastatic Spinal Cord Compression: A Survival Score Particularly Developed for Elderly Prostate Cancer Patients. (2015) (10)
Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer. (2015) (10)
Prognostic Factors Including the Expression of Thyroid Transcription Factor 1 (TTF1) in Patients Irradiated for Limited-disease Small Cell Lung Cancer. (2016) (10)
Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer (2014) (10)
NR2F6 as a Prognostic Biomarker in HNSCC (2020) (10)
Number of extraspinal organs with metastases: a prognostic factor of survival in patients with metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC). (2014) (10)
Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers (2017) (10)
Stereotactic radiotherapy in neovascular age-related macular degeneration (2016) (10)
Breast cancer patients with metastatic spinal cord compression (2014) (10)
Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer. (2013) (10)
Impact of stratified resection margin classification on local tumor control and survival in patients with oral squamous cell carcinoma (2021) (10)
A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression (2014) (10)
Palliative Radiation Therapy for Spinal Cord Compression from Metastatic Soft Tissue Sarcoma. (2016) (10)
A Tool to Estimate Survival of Elderly Patients Presenting with Metastatic Epidural Spinal Cord Compression (MESCC) from Cancer of Unknown Primary. (2015) (9)
Development of a Survival Score for Patients with Cerebral Metastases from Melanoma. (2017) (9)
Sleep Disorders in Patients With Breast Cancer Prior to a Course of Radiotherapy – Prevalence and Risk Factors (2021) (9)
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials (2021) (9)
A New Instrument for Predicting Survival of Patients with Cerebral Metastases from Breast Cancer Developed in a Homogeneously Treated Cohort (2019) (9)
Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex: Erratum (2017) (9)
Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases. (2015) (9)
Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? – a systematic review of the literature (2019) (9)
A New Phantom for Individual Verification of the Dose Distribution in Precision Radiotherapy for Head-and-Neck Cancer (2019) (9)
Stereotactic Radiosurgery Alone for One to Two Brain Metastases from Cancer of Unknown Primary. (2018) (9)
A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer. (2016) (9)
Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer. (2009) (9)
Application of a new verification technique allowing craniospinal irradiation in supine position. (2001) (9)
Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC) (2010) (9)
Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis (2020) (9)
Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer. (2017) (9)
Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer (2006) (9)
Karnofsky Performance Score Is Predictive of Survival After Palliative Irradiation of Metastatic Bile Duct Cancer. (2017) (8)
Prognosis of Patients with Metastatic Spinal Cord Compression from Adrenocortical Carcinoma. (2016) (8)
A Prognostic Instrument to Estimate the Survival of Elderly Patients Irradiated for Metastatic Epidural Spinal Cord Compression From Lung Cancer. (2016) (8)
Epidural and intramedullary spinal metastasis: clinical features and role of fractionated radiotherapy. (2018) (8)
Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer. (2016) (8)
Is surgery necessary following chemoradiation for patients with locally advanced cancer of the esophagus? (2007) (8)
Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck. (2016) (8)
A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers (2016) (8)
Metastatic spinal cord compression from pancreatic cancer. (2014) (8)
Predictors of survival in patients with brain metastases from gastric cancer. (2017) (8)
Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma (2018) (8)
A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression (2014) (8)
MicroRNA signatures in subtypes of follicular lymphoma. (2014) (8)
Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma. (2014) (8)
Comparison of 20×2 Gy and 12×3 Gy for Whole-brain Irradiation of Multiple Brain Metastases from Malignant Melanoma. (2016) (8)
Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases (2019) (8)
Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck (2014) (8)
Prognostic role of vascular endothelial growth factor and its receptor-1 in patients with esophageal cancer. (2014) (8)
A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery. (2015) (8)
Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer (2016) (8)
The number of involved extracranial organs: A new predictor of survival in breast cancer patients with brain metastasis (2013) (8)
Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer. (2016) (7)
Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective (2016) (7)
Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer. (2014) (7)
A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy. (2018) (7)
Evaluation of Pre-radiotherapy Sleep Disorders in Patients With Rectal or Anal Cancer (2021) (7)
Radiotherapeutic Options for Symptom Control in Breast Cancer (2011) (7)
A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression (2016) (7)
Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck. (2015) (7)
Radiotherapy is effective in the treatment of symptomatic vertebral hemangiomas (SVH): Long-term results of a multicenter study in germany (2004) (7)
Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer (2021) (7)
Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer. (2019) (7)
Is stereotactic radiosurgery the best treatment option for patients with spinal metastases? (2007) (7)
Reducing the Overall Treatment Time for Radiotherapy of Metastatic Spinal Cord Compression (MSCC): 3-Year Results of a Prospective Observational Multi-Center Study (2004) (7)
A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer (2019) (7)
p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction (2009) (7)
A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers (2016) (7)
Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer. (2016) (7)
Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved. (2013) (7)
A New Tool Predicting Survival After Radiosurgery Alone for One or Two Cerebral Metastases from Lung Cancer (2015) (7)
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma (2018) (7)
Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases. (2018) (6)
Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck (2013) (6)
Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer. (2014) (6)
Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck. (2013) (6)
Final results of a study comparing short-course and long-course radiotherapy (RT) for local control of metastatic spinal cord compression (MSCC). (2009) (6)
Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer. (2018) (6)
Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases (2019) (6)
Dose-Fractionation Schedules for Radiotherapy of Bone Metastases (2010) (6)
Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases (2019) (6)
A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer. (2017) (6)
Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration. (2017) (6)
Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer (2021) (6)
Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous? (2009) (6)
[The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP)]. (2001) (6)
International survey of the treatment of metastatic spinal cord compression. (2015) (6)
1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups (2018) (6)
Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer (2018) (6)
Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck Cancer (2021) (6)
Patient-reported outcomes - secondary analysis of the SCORE-2 trial comparing 4Gy x 5 to 3Gy x 10 for metastatic epidural spinal cord compression. (2019) (6)
The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma (2019) (6)
A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck. (2016) (6)
Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis. (2010) (5)
A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer (2015) (5)
Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer. (2017) (5)
Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer (2018) (5)
Emotional Problems Prior to Adjuvant Radiation Therapy for Breast Cancer (2021) (5)
A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression (2018) (5)
Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients. (2017) (5)
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2) (2020) (5)
The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future. (2016) (5)
Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database (2021) (5)
Double Positivity for HPV DNA/P16INK4a Does Not Influence Survival of Patients With Oral Squamous Cell Carcinoma (2021) (5)
Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial. (2018) (5)
Estimating survival of patients receiving radiosurgery alone for cerebral metastasis from melanoma (2014) (5)
Sleep Disturbances in Lung Cancer Patients Assigned to Definitive or Adjuvant Irradiation (2021) (5)
Inhibition of GSK3α/β impairs the progression of HNSCC (2018) (5)
Accelerated Fractionation With Concomitant Boost vs. Conventional Radio-chemotherapy for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head-and-Neck (SCCHN) (2021) (5)
Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer. (2016) (5)
Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck (2014) (5)
Prophylactic Radiotherapy to Intervention Sites in Malignant Pleural Mesothelioma--Single-institution Experience and Literature Review. (2015) (5)
[Bilateral breast carcinoma and local recurrence: prevalence of BRCA-1 and BRCA-2 gene mutations in an unselected patient sample]. (2001) (5)
High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study (2017) (5)
Forecasting Survival Probabilities After Radiotherapy of Metastatic Epidural Spinal Cord Compression from Colorectal Cancer in the Elderly. (2016) (5)
Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma. (2018) (5)
Re-Irradiation for Recurrent Glioblastoma Multiforme (2020) (5)
A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer. (2017) (5)
Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter? (2018) (5)
Frequency and Risk Factors of Sleep Disturbances in Patients With Prostate Cancer Assigned to Local or Loco-regional Radiotherapy (2021) (5)
Re-irradiation of spinal cord compression due to metastasis in elderly patients. (2014) (5)
Seizures Prior to Radiotherapy of Gliomas: Prevalence, Risk Factors and Survival Prognosis (2020) (5)
Radiosurgery with a Rotating Gamma System: A Very Effective Treatment for Symptomatic Cerebral Cavernomas. (2017) (5)
Therapy-related transcriptional subtypes in matched primary and recurrent head and neck cancer. (2021) (5)
Epoetin-alpha during radiotherapy for stage III esophageal carcinoma. (2005) (5)
An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer (2020) (4)
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer (2018) (4)
Pneumonitis after radiotherapy for lung cancer (PARALUC): an interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis (2020) (4)
LEOPARD-II: A randomized phase II study of radiochemotherapy (RCT) with 5FU and cisplatin plus/minus cetuximab (Cet) in unresectable locally advanced esophageal cancer (LAEC). (2014) (4)
Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly. (2017) (4)
Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients. (2015) (4)
A Scoring Instrument to Predict the Survival Prognoses of Patients with Metastatic Epidural Spinal Cord Compression from Gynecological Malignancies. (2016) (4)
Wearable electroencephalography for ultra-long-term seizure monitoring: a systematic review and future prospects (2021) (4)
Factors Impacting the Overall Survival of Patients Irradiated for Invasive Carcinoma of the Urinary Bladder. (2017) (4)
Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients (2019) (4)
Palliative Radiotherapy of Primary Glioblastoma (2021) (4)
Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases (2019) (4)
Sleep Disorders Prior to Adjuvant Radiation Therapy for Gynecological Malignancies (2021) (4)
Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression. (2017) (4)
Radiotherapy with or without Decompressive Surgery for Metastatic Spinal Cord Compression: A Retrospective Matched-Pair Study Including Data from Prospectively Evaluated Patients (2022) (4)
Radiotherapy Alone for Malignant Spinal Cord Compression in Young Men with Seminoma. (2016) (4)
Prognostic Factors After Whole-brain Radiotherapy Alone for Brain Metastases from Malignant Melanoma. (2016) (4)
A scoring system for predicting the survival prognosis of patients receiving stereotactic body radiation therapy (SBRT) for 1–3 lung metastases (2016) (4)
Radiation Therapy Alone Provides Excellent Outcomes for Spinal Cord Compression from Vertebral Lymphoma. (2016) (4)
Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter? (2018) (4)
A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG) (2021) (4)
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study (2020) (4)
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC (2022) (4)
Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers. (2016) (4)
Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer (2020) (4)
Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers (2022) (4)
Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks. (2016) (4)
A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers (2018) (4)
Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer. (2016) (4)
Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck (2015) (4)
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer. (2017) (3)
Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results. (2014) (3)
A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases (2020) (3)
Individualisation of Radiation Therapy for Older Persons With Secondary Brain Lesions from Carcinoma of the Breast (2020) (3)
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy (2020) (3)
Pre-operative Seizures in Patients With Single Brain Metastasis Treated With Resection Plus Whole-Brain Irradiation and a Boost (2020) (3)
Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas (2021) (3)
Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer. (2016) (3)
A new and easy-to-use survival score for patients irradiated for metastatic epidural spinal cord compression. (2022) (3)
Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands. (2017) (3)
Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly (2020) (3)
Personalized Radiotherapeutic Approaches for Elderly Patients with Epidural Cord Compression from Gastric Cancer. (2016) (3)
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM (2019) (3)
Estimating the Survival of Elderly Patients with Renal Cell Carcinoma Presenting with Malignant Spinal Cord Compression. (2016) (3)
An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer (2020) (3)
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC (2020) (3)
A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy. (2017) (3)
Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas (2021) (3)
Primary Breast Cancer with Synchronous Metastatic Disease - Indications for Local Radiotherapy to the Breast and Chest Wall. (2015) (3)
Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer (2019) (3)
Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases. (2016) (3)
A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses (2015) (3)
The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy (2005) (3)
Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region (2021) (3)
Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. (2017) (3)
Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary (2020) (3)
OC-0503: Impact of cardiac and respiratory motion during cardiac radiosurgery: a dose accumulation study in a porcine model (2014) (3)
Correction: Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology (2013) (3)
Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses (2019) (3)
The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1) (2021) (3)
The effects of metal artifact reduction on the retrieval of attenuation values (2016) (3)
Predicting the survival probability of gastric cancer patients developing metastatic epidural spinal cord compression (MESCC) (2015) (3)
OC-0022 EVALUATION OF A WAVELET-BASED LEAST MEAN SQUARE MOTION PREDICTION ALGORITHM FOR LUNG AND LIVER PATIENTS (2012) (3)
Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool (2019) (3)
Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer (2022) (3)
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. (2017) (3)
TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271. (2017) (3)
An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer (2020) (3)
Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients (2014) (3)
A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression (2022) (3)
Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer—A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT) (2022) (3)
Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer (2020) (2)
Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy (2021) (2)
Re-irradiation with 36 Gy (1.5 Gy Twice Daily) Plus Paclitaxel for Advanced Recurrent and Previously Irradiated SCCHN is Feasible. (2018) (2)
Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer. (2016) (2)
Radiation Therapy for Metastatic Disease (2011) (2)
Rotating Gamma System Irradiation: A Promising Treatment for Low-grade Brainstem Gliomas. (2017) (2)
A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases (2022) (2)
Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck (2023) (2)
Spinal cord compression (2007) (2)
Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO) (2019) (2)
Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients. (2015) (2)
A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck (2021) (2)
Erratum to: Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck (2013) (2)
Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy (2020) (2)
A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases (2020) (2)
Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression (2017) (2)
Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer (2018) (2)
Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer—a multicenter study (2020) (2)
Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer (2020) (2)
Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas (2020) (2)
Avoiding tracheal intubation in children during craniospinal irradiation (2001) (2)
Contents Vol. 45, 2001 (2001) (2)
A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder. (2017) (2)
Current Radiotherapy Concepts Regarding Brain and Bone Metastases in Centers Participating in the German-Danish Interreg-Project TreaT (2023) (2)
Conformal 3D planned radiotherapy for pelvic lymphoceles following surgery for urological cancer: A case study. (2016) (2)
Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases (2020) (2)
Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases (2020) (2)
Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenectomy for Pancreatic Adenocarcinoma: A Single-Center Experience (2021) (2)
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials (2021) (2)
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02) (2022) (2)
Erratum to: Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck (2013) (2)
Challenges of anemia correction during radiotherapy and chemoradiation (2012) (2)
A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (2021) (2)
Evaluation of Five Survival Scores in a Cohort of Elderly Patients With Cerebral Metastasis from Non-small Cell Lung Cancer (2020) (2)
Outcomes After Radio(chemo)therapy for Non-Metastatic Bile Duct Cancer. (2017) (2)
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM) (2020) (2)
Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients (2019) (2)
Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer (2018) (2)
Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A Regime. (2016) (2)
EP-1658: A scoring system to predict bone metastasis after radical resection of colorectal cancer (2018) (2)
Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer (2020) (2)
Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain Metastases. (2016) (1)
Comparison of Three Survival Scores in a Series of Patients ≥80 Years of Age Irradiated for Bone Metastases (2023) (1)
A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation (2020) (1)
A new score predicting the survival of patients with spinal cord compression from myeloma (2012) (1)
Improvement of Sleep Disorders During a Course of Radiotherapy for Breast Cancer - Final Results of the Prospective Interventional RADIO-SLEEP Trial (2022) (1)
20. Bone Metastases (2013) (1)
Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer. (2016) (1)
Seizures Prior to Whole-brain Irradiation for Metastatic Disease: Prevalence, Risk Factors and Association With Survival (2020) (1)
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials (2022) (1)
Lung cancer: Best supportive care — a reasonable option for patients with brain metastases? (2016) (1)
Extra-cerebral Metastasis – An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT) (2020) (1)
Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study (2022) (1)
The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer (2022) (1)
Short-Course Radiotherapy for Metastatic Spinal Cord Compression in Lung Cancer Patients (2005) (1)
Outcomes After Whole-brain Radiotherapy for Brain Metastases with 5×4 Gy: Importance of Overall Treatment Time. (2016) (1)
Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer (2022) (1)
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials (2022) (1)
The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer (2020) (1)
Elderly Patients With Single Brain Metastasis – Overall Survival After Surgery Plus Whole-Brain Irradiation and a Radiation Boost (2020) (1)
A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer (2008) (1)
The First Survival Score for Patients Aged ≥80 Years Irradiated for Brain Metastases (2022) (1)
Validation of Scoring Systems Predicting Survival and Post-RT Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) (2009) (1)
Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy (2022) (1)
Scoring systems predictive of survival and local control of patients irradiated for brain metastases. (2016) (1)
Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support (2016) (1)
Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival (2021) (1)
[The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH)]. (2010) (1)
Construction of a highly flexible head and neck phantom (2019) (1)
Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer (2008) (1)
OC-0567: 5x4 Gy vs. 10x3 Gy for metastatic spinal cord compression: Preliminary results of the SCORE-2 trial (2014) (1)
A Prognostic Tool to Estimate the Risk of Pneumonitis in Patients Irradiated for Lung Cancer (2022) (1)
Erratum to “A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone” [Radiother Oncol 108 (2013) 123–127] (2013) (1)
Karnofsky Performance Score – An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer (2021) (1)
Nuclear Pore Complex (2011) (1)
A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancer (2021) (1)
Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer (2014) (1)
Reply to the Role of postoperative radiotherapy for the treatment of gangliogliomas (2010) (1)
Connections are clearly more complexy. (2013) (1)
The value of positron emission tomography (PET) for individual therapeutic management in localised cancer of unknown primary (CUP) (2001) (1)
High Accuracy of Virtual Simulation with the Laser System Dorado CT4 (2007) (1)
Comparison of Whole Brain Radiotherapy (WBRT) Alone, WBRT Plus Stereotactic Radiosurgery, and Surgery Plus WBRT for 1-3 Brain Metastases (2008) (1)
Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival (2020) (1)
A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer (2012) (1)
Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer (2022) (1)
A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer (2020) (1)
Changes in Peripapillary Nerve Fiber Layer Thickness after Adjuvant Stereotactic Radiotherapy in Patients with Neovascular Age-Related Macular Degeneration (2017) (1)
A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy (2022) (1)
Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery? (2014) (1)
Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers (2022) (1)
A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression (2014) (1)
Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study (2020) (1)
PO-0953: Proteome profiles in PDAC patients with local recurrence after postoperative radiochemotherapy (2017) (0)
Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases (2019) (0)
294 PERIOPERATIVE THERAPY IN STAGE IA-III PANCREATIC CANCER – A CROSS-VALIDATION OF THE NATIONAL CANCER DATABASE (NCDB) AND THE GERMAN CANCER REGISTRY OF THE WORKING GROUP OF GERMAN CANCER CENTERS (WGCC/ADT) (2021) (0)
Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer (2020) (0)
A New Scoring Tool to Estimate Post-Treatment Ambulatory Status after Radiotherapy of Metastatic Spinal Cord Compression (2022) (0)
[Clinical aspects and care of radiogenic treatment side effects on the eye]. (2022) (0)
Response to the comments on Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis (2010) (0)
Role of Positron Emission Tomography with 18F-Fluorodesoxyglucose (PET-FDG) in the Care of Carcinomas of an Unknown Primary Site (2006) (0)
Letter to 'Central neurocytoma with craniospinal dissemination' by H. Takao et al. (2004) (0)
SP-0002: The role of radiotherapy for the treatment of brain metastases (2015) (0)
901 ORAL Impact of SNP's in risk genes on fibrosis after radiotherapy (2007) (0)
Reply to D.E. Spratt and N. Szerlip. (2016) (0)
Abstract: Retrieval of Attenuation Values by the Augmented Likelihood Image Reconstruction in the Presence of Metal Artefacts (2018) (0)
Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer—Final Results of the PARALUC Trial (2023) (0)
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases (2013) (0)
Prevalence of and Risk Factors for Emotional Distress in Patients Undergoing Radiotherapy for Lung Cancer (2023) (0)
CLINICAL TRIALS STUDY Genomic landscape of pancreatic neuroendocrine tumors (2014) (0)
Metastatic Epidural Spinal Cord Compression: Conventional Radiotherapy (2018) (0)
Outcomes of Perioperative Therapy Concepts in Stage IA-III Pancreatic Cancer – A Cross-Validation of National Cancer Database (NCDB) and German Cancer Registry of the Working Group of German Cancer Centers (WGCC/ADT) (2022) (0)
Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years (2022) (0)
Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC). (2023) (0)
A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers. (2018) (0)
A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses (2015) (0)
A Multi-Platform Treatment Planning Benchmark Study for Spinal Radiosurgery (2019) (0)
356 An ultrasonic-based (US-based) patient positioning system (I-Beam): first experiences (2005) (0)
Hypothalamic-Pituitary Axis Dysfunction after Whole Brain Radiotherapy – A Cohort Study (2020) (0)
Palliative Radiation Therapy (2009) (0)
A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression (2016) (0)
Erratum to: Androgen receptor expression (2014) (0)
Mobile applications in radiation oncology—current choices and future potentials (2023) (0)
High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study (2017) (0)
OC-0408 Higher-dose radiotherapy for metastatic spinal cord compression: First results of a phase II trial (2021) (0)
Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large b-cell lymphomas of the thyroid – A study of 21 cases (2015) (0)
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy (2022) (0)
Salvage Perioperative Interstitial High-Dose-Rate Interventional Radiotherapy (Brachytherapy) for Local Recurrences of the Chest Wall Following Mastectomy and Previous External Irradiation (2023) (0)
A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases (2017) (0)
Development of a new micro-injection-system for adenoviral gene delivery (MAGD). (2016) (0)
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study (2020) (0)
Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin (2022) (0)
Pre-treatment Emotional Distress in Patients Receiving Radiotherapy for Gynecologic Cancers (2023) (0)
Palliative Radiation Oncology: Personalized Approaches to Radiotherapeutic Technologies, Quality of Life, and End-of-life Cancer Care. (2023) (0)
Genomic landscape of pancreatic neuroendocrine tumors (2015) (0)
SP-0010 EXTRACRANIAL STEREOTACTIC RADIOSURGERY FOR SPINAL AND PARASPINAL METASTASIS (2012) (0)
Short Communication: Results of a Consensus Conference on Radiotherapy for Brain and Bone Metastases Within the Interreg-Project TreaT (2023) (0)
Peer-Review Reports 1 2 3 4 5 6 7 The Cost-Effectiveness of Stereotactic Radiosurgery versus Surgical Resection in the Treatment of Brain Metastasis in Vietnam from the Perspective of Patients and Families (2011) (0)
A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression (2018) (0)
Distress Scores During a Course of Radiotherapy: A Pilot Study (2022) (0)
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy (2022) (0)
Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck (2015) (0)
6526 POSTER Phase I Study of Definitive Chemoradiation With Cisplatin/5-FU Plus Cetuximab in Unresectable Esophageal Cancer (2011) (0)
Reply to the letter by M. Cengiz et al. (2004) (0)
Cardiac Radiosurgery: Preliminary Results in a Porcine Model and Possible Implications for the Treatment of Atrial Fibrillation (2013) (0)
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC (2023) (0)
58P Outcome and toxicity of reirradiation for locally recurrent small cell lung cancer: An international multicenter study (2021) (0)
2101 A prognostic factor in metastatic spinal cord compression: Time between onset of motoric deficits and beginning of irradiation (1999) (0)
Pre-treatment Emotional Distress in Patients Irradiated for Malignant Glioma (2023) (0)
Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action (2015) (0)
[Advantages of stereotactic body radiation vs. conventional radiation for spinal metastases]. (2013) (0)
EP-1565 Quality of online information about radiotherapy for prostate cancer (2019) (0)
Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer (2023) (0)
A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone (2014) (0)
in vivo Clinical Factors Associated with Treatment Outcomes F ollowing Whole-brain Irradiation in Patients with Prostate Cancer (2017) (0)
Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder (2018) (0)
Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy (2023) (0)
SP-0116: Advances in radiotherapy of spinal metastases (2014) (0)
Palliative Radiotherapy: Metastatic Spinal Cord Compression (2008) (0)
EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC) (2019) (0)
Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer (2014) (0)
A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer (2015) (0)
EP-1205: The prognostic role of Neutrophil-tolymphocyte ratio in limited disease small-cell lung cancer (2017) (0)
[Value of postoperative stereotaxic body radiation therapy for spinal metastases]. (2017) (0)
Erratum to: Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck (2014) (0)
Long-term radiation sequelae after breast conserving therapy in women with early-stage breast cancer treated with 2.5 Gy per fraction (2004) (0)
E18. CNS metastasis: The role of radiotherapy for brain metastasis and metastatic spinal cord compression (2010) (0)
A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG) (2021) (0)
O.477 Brachytherapy as adjuvant radiotherapy for treatment of head and neck cancer (2008) (0)
Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction (2022) (0)
Subject Index Vol. 45, 2001 (2001) (0)
Pneumonitis after radiotherapy for lung cancer (PARALUC): an interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis (2020) (0)
Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases (2016) (0)
Local Control of Metastatic Spinal Cord Compression Following Radiotherapy (2010) (0)
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases (2023) (0)
Palliative Radiotherapy for Malignant Epidural Spinal Cord Compression (2017) (0)
Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer (2018) (0)
Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer (2022) (0)
[The role of surgery for the management of resectable stage III non-small cell lung cancer]. (2016) (0)
2500 ORAL A score predicting overall survival in patients with metastatic spinal cord compression (2007) (0)
[Can 12- instead of 4‑weekly zoledronic acid administration reduce skeletal events in patients with bone metastases?] (2017) (0)
Predicting the Risk of Subsequent Distant Brain Metastases After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Elderly Patients (2020) (0)
Efficacy of Biological Isoeffect Distributions in Clinical Practice (1992) (0)
TH‐A‐BRA‐08: Retrospective Accuracy Estimation for Motion Compensated Robotic Radiosurgery of the Liver (2012) (0)
EP-1395 FILM BASED DELIVERY QUALITY ASSURANCE FOR ROBOTIC RADIOSURGERY (2012) (0)
Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary (2012) (0)
Treatment of cancer of the anal canal. The Hamburg experience. (2006) (0)
Extensive desmoplasia is associated with high expression of ZEB1 in pancreatic cancer cells and cancer associated fibroblasts determine prognosis (2019) (0)
Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer (2023) (0)
Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases (2023) (0)
Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma. (2016) (0)
Perioperative Therapy in Stage IA-III Pancreatic Cancer – A Cross-validation of the National Cancer Database and the German Cancer Registry (2021) (0)
PD-0489 PATIENT IMMOBILIZATION AND TARGET MOTION MANAGEMENT FOR FRACTIONATED INTRACRANIAL AND UVEAL ROBOTIC RADIOSURGERY (2012) (0)
Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway (2015) (0)
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers (2016) (0)
Title Radioprotective Effect of Lidocaine on NeurotransmitterAgonist-Induced Secretion in Irradiated Salivary Glands (2013) (0)
1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups (2018) (0)
Acquisita in Experimental Epidermolysis Bullosa Determine the Extent of Skin Inflammation Radiosensitive Hematopoietic Cells (2015) (0)
Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone (2023) (0)
Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO) (2019) (0)
Erratum to: Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck (2013) (0)
A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases (2017) (0)
Radiotherapy related skin toxicity (RAREST-02): A reminder app developed to reduce radiation dermatitis in patients with head-and-neck cancer (2019) (0)
A New Mathematical Model to Simulate the Progression of Brain Metastasis (2012) (0)
Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases (2019) (0)
Comment on: Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Author's reply (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dirk Rades?

Dirk Rades is affiliated with the following schools:

University of Lübeck
University of Hamburg

Dirk Rades's Academic­Influence.com Rankings

Dirk Rades's Degrees

Why Is Dirk Rades Influential?

Dirk Rades's Published Works

Published Works

What Schools Are Affiliated With Dirk Rades?

Dirk Rades's AcademicInfluence.com Rankings